Co-expression of multiple cytokines and their receptors in primary clear cell sarcoma of the pubic bone with features of a small round cell tumor

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 3, 2012, Pages 799-804

  Nakayama, S ^a   Yokote, T ^a   Iwaki, K ^a   Hirata, Y ^a   Akioka, T ^a   Miyoshi, T ^a   Takayama, A ^a   Nishiwaki, U ^a   Masuda, Y ^a   Tsuji, M ^a   Hanafusa, T ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Clear cell sarcoma; Cytokine; Granulocyte colony stimulating factor; Immunohistochemistry; Interleukin 6; Pubic bone; Small round cell tumor

Indexed keywords

C REACTIVE PROTEIN; CYTOKERATIN AE1; CYTOKERATIN AE3; CYTOKINE; CYTOKINE RECEPTOR; DACARBAZINE; EPITHELIAL MEMBRANE ANTIGEN; FORMALDEHYDE; GALLIUM CITRATE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MELAN A; NIMUSTINE; PARAFFIN; PROTEIN S 100; RNA BINDING PROTEIN EWS; RNA BINDING PROTEIN EWSR1; TECHNETIUM 99M; UNCLASSIFIED DRUG; VINCRISTINE;

AGED; ARTICLE; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME 22; CLEAR CELL SARCOMA; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; INTRON; LABORATORY TEST; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIVER METASTASIS; LUNG METASTASIS; LYMPHOCYTE; MALE; MEDICAL HISTORY; MELANOMA; NEEDLE BIOPSY; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUBIC BONE; SMALL CELL SARCOMA; TELOMERE; TUMOR CELL;

EID: 84868033076     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500330     Document Type: Article

References (33)

1. Enzinger FM. Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer 1965; 18: 1163-74.
2. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and son tissue tumors: clear cell sarcoma (malignant melanoma of soft parts). Cancer Genet Cytogenet 2001; 130:1-7. (Pubitemid 32982126)
3. Jakubauskas A, Valceckiene V, Andrekute K, Seinin D, Kanopka A, Griskevicius L. Discovery of two novel EWSRl/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation. Exp Mol Pathol 2011; 90: 194-200.
4. Yang L, Chen Y, Cui T, Knösel T, Zhang Q, Geier C, Katenkamp D, Petersen I. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma. Hum Pathol 2012 [ Epub ahead of print].
5. Wang WL, Mayordomo E, Zhang W, Hernandez VS, Tuvin D, Garcia L, Lev DC, Lazar AJ, López-Terrada D. Detection and characterization of EWSR1/ATF1 and EWSR1 /CREB1 chimeric transcripts in clear cell sarcoma (melanoma of son parts). Mod Pathol 2009; 22: 1201-9.
6. Langezaal SM, Graadt van Roggen JF, CletonJansen AM, Baelde JJ, Hogendoorn PC. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 2001; 84:535-8. (Pubitemid 32215882)
7. Hersekli MA, Ozkoc G, Bircan S, Akpinar S, Ozalay M, Tuncer I, Tandogan RN. Primary clear cell sarcoma of rib. Skeletal Radiol 2005; 34:167-70. (Pubitemid 40305458)
8. Liu X, Zhang H, Dong Y. Primary clear cell sarcoma of humerus: Case report. World J Surg Oncol 2011; 9: 163.
9. Zhang W, Shen Y, Wan R, Zhu Y. Primary clear cell sarcoma of the sacrum: A case report. Skeletal Radiol 2011; 40: 633-9.
10. Rocco G, de Chiara AR, Fazioli F, Scognamiglio F, La Rocca A, Apice G, Riva C. Primary giant clear cell sarcoma (soft tissue malignant melanoma) of the sternum. Ann Thorac Surg 2009; 87: 1927-8.
11. Fayad L, Keating MJ, Reuben JM, O'Berian S, Lee BN, Lerner S, Kurzrock R. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood 2001; 97:256-63. (Pubitemid 32061268)
12. Stoiser B, Looareesuman S, Thalhammer F, Daxbock F, Chullawichit S, El-Menyawi I, Graninger W, Burgmann H. Serum concentrations of granulocytecolony stimulating factor in complicated plasmodium falciparum malaria. Eur Cytokine Netw 2000; 11: 7580.
13. Patel RM, Downs-Kelly E, Weiss SW, Folpe AL, Tubbs RR, Tuthill RJ, Goldblum JR, Skácel M. Dualcolor, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma. Mod Pathol 2005; 18:1585-90. (Pubitemid 41670657)
14. Fujimoto M, Hiraga M, Kiyosawa T, Murakami T, Murata S, Ohtsuki M, Nakagawa H. Complete remission of metastatic clear cell sarcoma with DAV chemotherapy. Clin Exp Dermatol 2003; 28:22-4. (Pubitemid 36197555)
15. Moretti S, Pinzi C, Spallanzani A, et al. Immunohistochemical evidence of cytokine networks during progression of human melanocyte lesions. Int J Cancer 1999; 84:160-8. (Pubitemid 29133828)
16. Kishimoto T. The biology of interleukin-6. Blood 74: 1-10.
17. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002; 8:945-54. (Pubitemid 35177340)
18. Yee C, Biondi A, Wang XH, et al. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood 1989; 74:798-804 (Pubitemid 19208825)
19. Mouawad R, Benhammouda A, Rixe O, Antoine EC, Borel C, Weil M, Khayat D, Soubrane C. Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden. Clin Cancer Res 1996; 2:1405-9. (Pubitemid 26299441)
20. Moretti S, Pinzi C, Spallanzani A, Berti E, Chiarugi A, Mazzoli S, Fabiani M, Vallecchi C, Herlyn M. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer 1999; 84:160-8. (Pubitemid 29133828)
21. Terai M, Eto M, Young GD, Berd D, Mastrangelo MJ, Tamura Y, Harigaya K, Sato T. Interleukin 6 mediates production of interleukin 10 in metastatic melanoma. Cancer Immunol Immunother 2012; 61: 145-55.
22. Nagata S. Fas and Fas ligand: A death factor and its receptor. Adv Immunol 1994; 57: 129-44.
23. Mouawad R, Antoine EC, Khayat D, Soubrane C. Effect of endogenous interleukin-6 on Fas (APO-1/ CD95) receptor expression in advanced melanoma patients. Cytokines Cell Mol Ther 2000; 6:135-40. (Pubitemid 32098586)
24. Lu C, Kerbel RS. Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol 1993; 120:1281-8. (Pubitemid 23064182)
25. Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229-37.
26. Berdel WE, Danhauser-Riedl S, Steinhauser G, Winton EF. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 1989; 73:80-3. (Pubitemid 19040957)
27. Nagata S, Tsuchiya M, Asano S, et al. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986; 319:415-8. (Pubitemid 16163903)
28. Nishizawa M, Tsuchiya M, Watanabe-Fukunaga R, Nagata S. Multiple elements in the promoter of granulocyte colony-stimulating factor gene regulate its constitutive expression in human carcinoma cells. J Biol Chem 1990; 265: 5897-902.
29. Weite K, Platzer E, Lu L, Gabrilove JL, Levi E, Mertelsmann R, Moore MA. Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor. Proc Natl Acad Sci USA 1985; 82:1526-30. (Pubitemid 15120576)
30. Stan AC, Walter GF, Weite K, Pietsch T. Immunolocalization of granulocyte-colonystimulating factor in human glial and primitive neuroectodermal tumors. Int J Cancer 1994; 57: 30612.
31. Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992; 80: 374-81.
32. Shih IM, Herlyn M. Role of growth factors and their receptors in the development and progression of melanoma J Invest Dermatol 1993; 100:196S-203S. (Pubitemid 23051698)
33. Bahrami A, Truong LD, Ro JY. Undifferentiated tumor: true identity by immunohistochemistry. Arch Pathol Lab Med 2008; 132:326-48. (Pubitemid 351328809)